Global Hemophilia Drugs Market Professional Survey Report 2017
- QYR1615611
- 122 Pages
- September 2017
- Healthcare
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Baxalta
Bayer
CSL Behring
Novo Nordisk
Pfizer
Roche
Alnylam Pharmaceuticals
Amarna Therapeutics
Asklepios BioPharmaceutical
Biogen
BioMarin
Catalyst Bioscience
Chiesi Farmaceutici
Dimension Therapeutics
Emergent BioSolutions
Grifols, Kedrion Biopharma
Octapharma
rEVO Biologics
OPKO Biologics
Sangamo Biosciences
Spark Therapeutics
Swedish Orphan Biovitrum
UniQure Biopharma.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Hemophilia A
Hemophilia B
Hemophilia C
By Application, the market can be split into
Clinic
Hospital
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Hemophilia Drugs Market Professional Survey Report 2017
1 Industry Overview of Hemophilia Drugs
1.1 Definition and Specifications of Hemophilia Drugs
1.1.1 Definition of Hemophilia Drugs
1.1.2 Specifications of Hemophilia Drugs
1.2 Classification of Hemophilia Drugs
1.2.1 Hemophilia A
1.2.2 Hemophilia B
1.2.3 Hemophilia C
1.3 Applications of Hemophilia Drugs
1.3.1 Clinic
1.3.2 Hospital
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Hemophilia Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hemophilia Drugs
2.3 Manufacturing Process Analysis of Hemophilia Drugs
2.4 Industry Chain Structure of Hemophilia Drugs
3 Technical Data and Manufacturing Plants Analysis of Hemophilia Drugs
3.1 Capacity and Commercial Production Date of Global Hemophilia Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Hemophilia Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Hemophilia Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Hemophilia Drugs Major Manufacturers in 2016
4 Global Hemophilia Drugs Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Hemophilia Drugs Capacity and Growth Rate Analysis
4.2.2 2016 Hemophilia Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Hemophilia Drugs Sales and Growth Rate Analysis
4.3.2 2016 Hemophilia Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Hemophilia Drugs Sales Price
4.4.2 2016 Hemophilia Drugs Sales Price Analysis (Company Segment)
5 Hemophilia Drugs Regional Market Analysis
5.1 North America Hemophilia Drugs Market Analysis
5.1.1 North America Hemophilia Drugs Market Overview
5.1.2 North America 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Hemophilia Drugs Sales Price Analysis
5.1.4 North America 2016 Hemophilia Drugs Market Share Analysis
5.2 China Hemophilia Drugs Market Analysis
5.2.1 China Hemophilia Drugs Market Overview
5.2.2 China 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Hemophilia Drugs Sales Price Analysis
5.2.4 China 2016 Hemophilia Drugs Market Share Analysis
5.3 Europe Hemophilia Drugs Market Analysis
5.3.1 Europe Hemophilia Drugs Market Overview
5.3.2 Europe 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Hemophilia Drugs Sales Price Analysis
5.3.4 Europe 2016 Hemophilia Drugs Market Share Analysis
5.4 Southeast Asia Hemophilia Drugs Market Analysis
5.4.1 Southeast Asia Hemophilia Drugs Market Overview
5.4.2 Southeast Asia 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Hemophilia Drugs Sales Price Analysis
5.4.4 Southeast Asia 2016 Hemophilia Drugs Market Share Analysis
5.5 Japan Hemophilia Drugs Market Analysis
5.5.1 Japan Hemophilia Drugs Market Overview
5.5.2 Japan 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Hemophilia Drugs Sales Price Analysis
5.5.4 Japan 2016 Hemophilia Drugs Market Share Analysis
5.6 India Hemophilia Drugs Market Analysis
5.6.1 India Hemophilia Drugs Market Overview
5.6.2 India 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Hemophilia Drugs Sales Price Analysis
5.6.4 India 2016 Hemophilia Drugs Market Share Analysis
6 Global 2012-2017E Hemophilia Drugs Segment Market Analysis (by Type)
6.1 Global 2012-2017E Hemophilia Drugs Sales by Type
6.2 Different Types of Hemophilia Drugs Product Interview Price Analysis
6.3 Different Types of Hemophilia Drugs Product Driving Factors Analysis
6.3.1 Hemophilia A of Hemophilia Drugs Growth Driving Factor Analysis
6.3.2 Hemophilia B of Hemophilia Drugs Growth Driving Factor Analysis
6.3.3 Hemophilia C of Hemophilia Drugs Growth Driving Factor Analysis
7 Global 2012-2017E Hemophilia Drugs Segment Market Analysis (by Application)
7.1 Global 2012-2017E Hemophilia Drugs Consumption by Application
7.2 Different Application of Hemophilia Drugs Product Interview Price Analysis
7.3 Different Application of Hemophilia Drugs Product Driving Factors Analysis
7.3.1 Clinic of Hemophilia Drugs Growth Driving Factor Analysis
7.3.2 Hospital of Hemophilia Drugs Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Hemophilia Drugs
8.1 Baxalta
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Baxalta 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Baxalta 2016 Hemophilia Drugs Business Region Distribution Analysis
8.2 Bayer
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Bayer 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Bayer 2016 Hemophilia Drugs Business Region Distribution Analysis
8.3 CSL Behring
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 CSL Behring 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 CSL Behring 2016 Hemophilia Drugs Business Region Distribution Analysis
8.4 Novo Nordisk
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Novo Nordisk 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Novo Nordisk 2016 Hemophilia Drugs Business Region Distribution Analysis
8.5 Pfizer
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Pfizer 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Pfizer 2016 Hemophilia Drugs Business Region Distribution Analysis
8.6 Roche
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Roche 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Roche 2016 Hemophilia Drugs Business Region Distribution Analysis
8.7 Alnylam Pharmaceuticals
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Alnylam Pharmaceuticals 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Alnylam Pharmaceuticals 2016 Hemophilia Drugs Business Region Distribution Analysis
8.8 Amarna Therapeutics
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Amarna Therapeutics 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Amarna Therapeutics 2016 Hemophilia Drugs Business Region Distribution Analysis
8.9 Asklepios BioPharmaceutical
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Asklepios BioPharmaceutical 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Asklepios BioPharmaceutical 2016 Hemophilia Drugs Business Region Distribution Analysis
8.10 Biogen
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Biogen 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Biogen 2016 Hemophilia Drugs Business Region Distribution Analysis
8.11 BioMarin
8.12 Catalyst Bioscience
8.13 Chiesi Farmaceutici
8.14 Dimension Therapeutics
8.15 Emergent BioSolutions
8.16 Grifols, Kedrion Biopharma
8.17 Octapharma
8.18 rEVO Biologics
8.19 OPKO Biologics
8.20 Sangamo Biosciences
8.21 Spark Therapeutics
8.22 Swedish Orphan Biovitrum
8.23 UniQure Biopharma.
9 Development Trend of Analysis of Hemophilia Drugs Market
9.1 Global Hemophilia Drugs Market Trend Analysis
9.1.1 Global 2017-2022 Hemophilia Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Hemophilia Drugs Sales Price Forecast
9.2 Hemophilia Drugs Regional Market Trend
9.2.1 North America 2017-2022 Hemophilia Drugs Consumption Forecast
9.2.2 China 2017-2022 Hemophilia Drugs Consumption Forecast
9.2.3 Europe 2017-2022 Hemophilia Drugs Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Hemophilia Drugs Consumption Forecast
9.2.5 Japan 2017-2022 Hemophilia Drugs Consumption Forecast
9.2.6 India 2017-2022 Hemophilia Drugs Consumption Forecast
9.3 Hemophilia Drugs Market Trend (Product Type)
9.4 Hemophilia Drugs Market Trend (Application)
10 Hemophilia Drugs Marketing Type Analysis
10.1 Hemophilia Drugs Regional Marketing Type Analysis
10.2 Hemophilia Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Hemophilia Drugs by Region
10.4 Hemophilia Drugs Supply Chain Analysis
11 Consumers Analysis of Hemophilia Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Hemophilia Drugs Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
Figure Picture of Hemophilia Drugs
Table Product Specifications of Hemophilia Drugs
Table Classification of Hemophilia Drugs
Figure Global Production Market Share of Hemophilia Drugs by Type in 2016
Figure Hemophilia A Picture
Table Major Manufacturers of Hemophilia A
Figure Hemophilia B Picture
Table Major Manufacturers of Hemophilia B
Figure Hemophilia C Picture
Table Major Manufacturers of Hemophilia C
Table Applications of Hemophilia Drugs
Figure Global Consumption Volume Market Share of Hemophilia Drugs by Application in 2016
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Market Share of Hemophilia Drugs by Regions
Figure North America Hemophilia Drugs Market Size (Million USD) (2012-2022)
Figure China Hemophilia Drugs Market Size (Million USD) (2012-2022)
Figure Europe Hemophilia Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Hemophilia Drugs Market Size (Million USD) (2012-2022)
Figure Japan Hemophilia Drugs Market Size (Million USD) (2012-2022)
Figure India Hemophilia Drugs Market Size (Million USD) (2012-2022)
Table Hemophilia Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hemophilia Drugs in 2016
Figure Manufacturing Process Analysis of Hemophilia Drugs
Figure Industry Chain Structure of Hemophilia Drugs
Table Capacity and Commercial Production Date of Global Hemophilia Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Hemophilia Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Hemophilia Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Hemophilia Drugs Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Hemophilia Drugs 2012-2017
Figure Global 2012-2017E Hemophilia Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Hemophilia Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Hemophilia Drugs Capacity and Growth Rate
Table 2016 Global Hemophilia Drugs Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Hemophilia Drugs Sales (K MT) and Growth Rate
Table 2016 Global Hemophilia Drugs Sales (K MT) List (Company Segment)
Table 2012-2017E Global Hemophilia Drugs Sales Price (USD/MT)
Table 2016 Global Hemophilia Drugs Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E
Figure North America 2012-2017E Hemophilia Drugs Sales Price (USD/MT)
Figure North America 2016 Hemophilia Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E
Figure China 2012-2017E Hemophilia Drugs Sales Price (USD/MT)
Figure China 2016 Hemophilia Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E
Figure Europe 2012-2017E Hemophilia Drugs Sales Price (USD/MT)
Figure Europe 2016 Hemophilia Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Hemophilia Drugs Sales Price (USD/MT)
Figure Southeast Asia 2016 Hemophilia Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E
Figure Japan 2012-2017E Hemophilia Drugs Sales Price (USD/MT)
Figure Japan 2016 Hemophilia Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E
Figure India 2012-2017E Hemophilia Drugs Sales Price (USD/MT)
Figure India 2016 Hemophilia Drugs Sales Market Share
Table Global 2012-2017E Hemophilia Drugs Sales (K MT) by Type
Table Different Types Hemophilia Drugs Product Interview Price
Table Global 2012-2017E Hemophilia Drugs Sales (K MT) by Application
Table Different Application Hemophilia Drugs Product Interview Price
Table Baxalta Information List
Table Product A Overview
Table Product B Overview
Table 2016 Baxalta Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Baxalta Hemophilia Drugs Business Region Distribution
Table Bayer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Bayer Hemophilia Drugs Business Region Distribution
Table CSL Behring Information List
Table Product A Overview
Table Product B Overview
Table 2015 CSL Behring Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 CSL Behring Hemophilia Drugs Business Region Distribution
Table Novo Nordisk Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novo Nordisk Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Novo Nordisk Hemophilia Drugs Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Pfizer Hemophilia Drugs Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Roche Hemophilia Drugs Business Region Distribution
Table Alnylam Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Alnylam Pharmaceuticals Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Alnylam Pharmaceuticals Hemophilia Drugs Business Region Distribution
Table Amarna Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amarna Therapeutics Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Amarna Therapeutics Hemophilia Drugs Business Region Distribution
Table Asklepios BioPharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Asklepios BioPharmaceutical Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Asklepios BioPharmaceutical Hemophilia Drugs Business Region Distribution
Table Biogen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Biogen Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Biogen Hemophilia Drugs Business Region Distribution
Table BioMarin Information List
Table Catalyst Bioscience Information List
Table Chiesi Farmaceutici Information List
Table Dimension Therapeutics Information List
Table Emergent BioSolutions Information List
Table Grifols, Kedrion Biopharma Information List
Table Octapharma Information List
Table rEVO Biologics Information List
Table OPKO Biologics Information List
Table Sangamo Biosciences Information List
Table Spark Therapeutics Information List
Table Swedish Orphan Biovitrum Information List
Table UniQure Biopharma. Information List
Figure Global 2017-2022 Hemophilia Drugs Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Hemophilia Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Hemophilia Drugs Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Hemophilia Drugs by Type 2017-2022
Table Global Consumption Volume (K MT) of Hemophilia Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Hemophilia Drugs by Region
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
